A prospective study of neurodevelopment of uninfected children born to human immunodeficiency virus type 1 positive mothers;Estudio prospective comparativo sobre el desarrollo psicomotor de niños, nacidos de madres positivas para el virus de inmunodeficiencia humana tipo 1 no infectados

Revista de Neurologia

Volumn 48, Issue 6, 2009, Pages 287-291

  Gomez C ^a   Archila, M E ^a   Rugeles, C ^a   Carrizosa, J ^a   Rugeles, M T ^a   Cornejo, J W ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Bayley II test; Denver II test; HIV 1; Neurodevelopment; Neurological examination; Psychomotor performance; Uninfected exposed infants

Indexed keywords

ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD DEVELOPMENT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MOTHER; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; PROSPECTIVE STUDY; VIROLOGY;

CENTRAL NERVOUS SYSTEM; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; MOTHERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES;

EID: 65149099409     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4806.2008400     Document Type: Article

References (50)

1. UNAIDS/OMS. AIDS epidemic update 2007. UNAIDS/OMS; 2007. URL: http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf [26.11.2008].
2. Núñez RL. Situación y tendencias epidemioló gicas de la infección por VIH/sida en Colombia. Iatreia 2004; 17: 297-9.
3. Orejón de Luna G. Afectación neurológica en niños con HIV. Rev Neu-rol 1996; 24: 278-84.
4. Lobato M, Caldwell B, Oxtoby M. The pediatric spectrum of disease consortium: encephalopathy in children with perinatally acquired HIV-1 infection. J Pediatric 1995; 126: 710-5.
5. Chase C, Ware J, Hittelman J, Blasini I, Smith R, Llorente A, et al. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics 2000; 106: e25.
6. Bruck I, Tahan TT, Cruz CR, Martins LT, Antoniuk SA, Rodrigues M, et al. Developmental milestones of vertically HIV infected and sero-reverters children: follow up of 83 children. Arq Neuropsiquiatr 2001; 59: 691-5.
7. Macmillan C, Magder LS, Brouwers P, Chase C, Hittelman J, Lasky T, et al. Head growth and neurodevelopment of infants born to HIV-1-in-fected drug-using women. Neurology 2001; 57: 1402-11.
8. Gay CL, Armstrong FD, Cohen D, Lai S, Hardy MD, Swales TP, et al. The effects of HIV on cognitive and motor development in children born to HIV-seropositive women with no reported drug use: birth to 24 months. Pediatrics 1995; 96: 1078-82.
9. Drotar D, Olness K, Wiznitzer M, Guay L, Marum L, Svilar G, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics 1997; 100: e5.
10. Knight NG, Mellins CA, Levenson RL. Effects of pediatric HIV infection on mental and psychomotor development. J Pediatr Psychol 1994; 16: 617-27.
11. Raskino C, Pearson DA, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nu-cleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team. Pediatrics 1999; 104: e32.
12. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ. HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group. Neurology 2000; 54: 1089-95.
13. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS. The neuropathogenesis of HIV-1 infection. J Leukoc Biol 1994; 56: 389-98.
14. Czornyj LA. Encefalopatía en niños con infección por virus de inmu-nodeficiencia humana de transmisión vertical. Rev Neurol 2006; 42: 743-53.
15. Tellechea-Rotta N, Legido A. Síndrome de inmunodeficiencia adquiri-da por transmision vertical: alteraciones neurológicas. Rev Neurol 2003; 36: 255-63.
16. Rotta NT, Silva C, Ohlweiler L, Lago I, Cabral R, Goncalves F, et al. Manifestaciones neurológicas del sida en la infancia. Rev Neurol 1999; 29: 319-22.
17. Millana-Cuevas LC, Portellano JA, Martínez-Arias R. Alteraciones neu-ropsicológicas en niños infectados por el virus de inmunodeficiencia humana. Rev Neurol 2007; 44: 366-74.
18. Garden GA. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 2002; 40: 240-51.
19. Burns T, Clough JA, Klein RM, Wood GW, Berman NE. Developmental regulation of citokyne expression in the mouse brain. Growth Factors 1993; 9: 253-8.
20. Patterson PH, Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 1993 ;72 (Suppl): S123-37.
21. Giulian KV, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 14: 1593-6.
22. Pulliam L, McGrath M, McGuire D. Monokine products as predictors of aids dementia. AIDS 1996; 10: 1495-500.
23. Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and as-trocytes. A hit and run phenomenon. J Biol Chem 1999; 274: 17098-102.
24. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, et al. Cell death and control of cell survival in the oligodendro- cyte lineage. Cell 1992; 70: 31-46.
25. Selmaj K, Raine C, Farooq M, Norton W. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by limphotoxin. J Immunol 1991; 147: 1522-9.
26. Campbell I, Kemper P, Mucke L. Neurologic disease induced in trans-genic mice by the cerebral overexpression of interleukin-6. Proc Natl Acad Sci U S A 1993; 90: 10061-5.
27. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, et al. Intracellular CXCR4 signaling, neuronal apoptosis and neuropatho- genic mechanisms of HIV-1-associated dementia. J Neuroimmunol 1999; 98: 185-200.
28. Kitayama H, Miura Y, Ando Y, Hoshino S, Ishizaka Y, Koyanagi Y. Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction. J Virol 2008; 82: 2528-42.
29. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D. Neuronal apopto- sis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neu-rotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998; 4: 281-90.
30. Kolson D, Buchhalter J, Collman R, Hellming B, Farrell C, Debouck C, et al. Tat alters normal organization of neurons and astrocytes in primary rodent brain cell culture: RGD sequence dependence. AIDS Res Hum Retroviruses 1993; 9: 677-85.
31. Ling Y, Jones M, Laribee N. Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 2000; 6: 1380-7.
32. Butera ST, Roberts BD, Folks TM. Regulation of HIV-1 expression by cytokine networks in a CD4+ model of chronic infection. J Immunol 1993; 150: 625-34.
33. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238: 800-2.
34. Volmink J, Siegfried NL, Van der Merwe L, Brocklehurst P. Antiretro-virals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2007; 1: CD003510.
35. Poirier MC, Olivero OA, Walker DM, Walker VE. Perinatal genotoxi-city and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol 2004; 199: 151-61.
36. Alimenti A, Forbes JC, Oberlander TF, Money DM, Grunau RE, Paps-dorf MP, et al. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Pediatrics 2006; 118: e1139-45.
37. Noyola DE, Demmler GJ, Nelson CT, Griesser C, Williamson WD, Atkins JT, et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2001; 138: 325-31.
38. Johnson JL, Leff M. Children of substance abusers: overview of research findings. Pediatrics 1999; 103: 1085-99.
39. a Asamblea Medica Mundial; 2004.
40. Bayley N. Bayley Scales of Infant Development. 2 ed. San Antonio: The Psychological Corporation/Harcourt Brace; 1993.
41. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick, B. The Denver II Training Manual. Denver: Denver Developmental Materials; 1992.
42. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 2005; 12 (Supl 1): 878-92.
43. Borkowsky W, Krasinski K, Moore T, Papaevangelou V. Lymphocyte proliferative responses to VIH-1 envelope and core antigens by infec-ted and uninfected adults and children. Aids Res Hum Retrovir 1990; 6: 673-8.
44. De Maria A, Cirillo C, Moretta L. Occurrence of HIV-1 specific cy-tolitic T cell activity in apparently uninfected children born to HIV-1 infected mothers J Infect Dis 1994; 170: 1296-301.
45. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96: 3866-71.
46. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4: 358-61.
47. Brinkman K, Ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998; 12: 1735-44.
48. Korenke GC, Hunneman DH, Eber S, Hanefeld F. Severe encephalopa-thy with epilepsy in an infant caused by subclinical maternal pernicious anaemia: case report and review of the literature. Eur J Pediatr 2004; 163: 196-201.
49. Pearson DA, McGrath NM, Nozyce M, Nichols SL, Raskino C, Brou- wers P, et al. Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS Clinical Trials 152 Study Team. Pediatrics 2000; 106: e76.
50. Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willough-by A. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994; 94: 883-91.